← Back to all trials
Completed
NCT05650372
High Intensity vs Low Intensity Resistive Exercise In Patient With Upper Extremity Lymphedema
Conditions: Lymphedema
Sex: All
Ages: 35 Years – 60 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 36
Sponsor: Biruni University
Location: Turkey
Summary
Lymphedema results from impaired lymphatic transport with increased limb volume.
The results of systematic reviews indicate that breast cancer survivors can perform resistance exercise training at high-enough intensities to elicit strength gains without triggering changes to lymphedema status.
There is strong evidence indicating that ret produces significant gains in muscular strength without provoking breast cancer-related lymphedema.
On the one hand, the literature studies say future exercise programs will have to be evaluated in detail regarding intensity, volume, duration, frequency, and exercised muscle group.
The purpose of this study is to examine the impact of upper body resistance exercise on the arm circumference, grip strength, pain, musculoskeletal disorders of the upper limbs, self-reported lymphedema symptoms, pinch strength, lymphedema functioning, disability, and health questionnaire/lymph-ıcf patient with upper extremity lymphedema and to compare these effects between resistance exercise involving high and low loads (heavier vs lighter weights).
Eligibility Criteria
Inclusion Criteria:Having been diagnosed with lymphedema of the upper extremity at least 6 months ago by the physicianHaving stage 2 lymphedemaHaving a circumference difference of 2-8 cm at any reference point between the affected extremity and the healthy extremityBeing between the ages of 35-60Volunteer to participateNot receiving lymphedema treatment in the last 6 monthsExclusion Criteria:Having stage 1 or 3 lymphedemaHave a greater than 8 cm less than 2 cm circumference difference any reference point between the affected extremity and the healthy extremityPapilloma, lymphedema or elephanthiasis with hyperkeratosisHave acute inflammatory diseases
Source: ClinicalTrials.gov (NCT05650372). StuddyBuddy aggregates publicly available trial information.
